PRLD
Prelude Therapeutics Inc
3.90$
+1.3%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -688.6% | – | – | -909.9% | -518.6% | – | – | -294.1% | 409.9% | -473.5% | -273.0% | -148.3% | |
| – | 9.7% | – | – | 13.5% | 12.2% | – | – | 6.5% | 5.1% | 8.5% | 6.2% | 6.5% | |
| – | 172.7% | – | – | 197.5% | 94.4% | – | – | 37.3% | 32.7% | 43.7% | 35.5% | 37.0% | |
| – | 108.6% | – | – | -31.1% | 107.2% | – | – | -39.6% | 658.1% | -298.9% | -72.1% | 74.7% | |
| – | 33.0% | – | – | 2.1% | 1.3% | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | 225.9% | – | – | 357.8% | 552.9% | – | – | 616.8% | -1,069.8% | 185.6% | -1,148.4% | -344.5% | |
| – | 0.0% | – | – | 0.0% | – | – | – | -0.1% | – | – | – | – | |
| – | – | – | – | -4.9% | -3.8% | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | 737.1% | – | – | -4.4% | -0.9% | – | – | -0.1% | 442.3% | -6.9% | 1,504.6% | 492.5% | |
| – | 274.4% | – | – | -556.5% | 33.5% | – | – | 322.6% | -217.7% | -294.8% | 83.2% | -0.3% | |
| – | -721.6% | – | – | -912.0% | -519.9% | – | – | -294.1% | 409.9% | -473.5% | -273.0% | -148.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.